FDA lacks sterility assurance for Medaus products

The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals and patients not to use unexpired drug products that are intended to be sterile that were produced by Medaus Pharmacy in Birmingham, Alabama, due to lack of sterility assurance. Medaus’ products were distributed nationwide and internationally. FDA advises checking medical supplies immediately, and any Medaus product marked as sterile be quarantined and should not administered. Read the FDA alert.